Table 2.
Participants' characteristics.
| Baseline characteristics | Value | |
|---|---|---|
| Treatment (n = 32) | Control (n = 34) | |
| Age (years old) | 68.09 (±3.00) | 67.32 (±2.28) |
| Younger old people (60-69) | 20 (62.5) | 26 (76.5) |
| Older old people (≥70) | 12 (37.5) | 8 (23.5) |
| Sex | ||
| Male | 13 (40.6) | 11 (32.4) |
| Female | 19 (59.4) | 23 (67.6) |
| GDNF level (ng/mL) | 0.90 (±0.31) | 1.24 (±0.42) |
| Cognitive function (MoCA) | 18.03 (±3.16) | 19.09 (±2.71) |
| Postural balance (TUG) | 21.97 (±4.03) | 19.32 (±3.98) |
| Postural balance (POMA) | 21.91 (±2.73) | 22.59 (±3.09) |
Values are presented as number (%) or mean ± standard deviation. GDNF: glial cell line-derived neurotrophic factor; MoCA: Montreal cognitive assessment; TUG: timed up and go; POMA: performance-oriented mobility assessment.